Androgen Deprivation Therapy (ADT) trials for Prostate cancer

All Androgen Deprivation Therapy (ADT) trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Androgen Deprivation Therapy (ADT) for Prostate cancer

• A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer
  NCT06320067 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 18 locations
• A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
  NCT06952803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 692 locations
• A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
  NCT07570979 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 3 locations
• Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
  NCT07237269 · Phase: Phase 2 · Ages: 30 Years and older · Sex: Male · 1 location
• Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial)
  NCT06772441 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
  NCT06150417 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 3 locations
• Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.
  NCT07483658 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 4 locations
• PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer
  NCT07426055 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: Male · 1 location
• PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer
  NCT07426094 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: Male · 1 location
• Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)
  NCT07313241 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation
  NCT05790213 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Radiotherapy After Prostatectomy for Node Positive Prostate Cancer
  NCT07477626 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 13 locations
• Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
  NCT05753566 · Phase: Phase 2 · Ages: 40 Years and older · Sex: Male · 2 locations
• Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
  NCT06305832 · Phase: Phase 2 · Ages: 40 Years and older · Sex: Male · 2 locations
• Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer
  NCT07801664 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)
  NCT07142967 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials study Androgen Deprivation Therapy (ADT) for Prostate cancer?

16 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.